Latest News

Buffett's favorite holding period is "forever", but this quote better explains why he doesn't worry about stock prices.

Given the nature of their businesses, Tesla and SpaceX's exposure to political risk won't subside anytime soon.

ASML and Nvidia sit at opposite ends of the chip supply chain, and their valuations tell very different stories for investors weighing new money.

Anthropic could start its life as a publicly traded company with a bang.

The news that led Jensen Huang to step down as CEO of Nvidia has crushed the company's stock price.

Two payments and data giants, one a premium card network and the other a gatekeeper of ratings and benchmarks, offer very different paths to growth and risk.

These five stocks have proven track records of dividend growth backed by attractive businesses.

There are good reasons to be bullish about CoreWeave stock, but the risk is real too.

Operating leverage lets Fastly add revenue without matching hardware costs, a structural edge that matters as global traffic keeps climbing.

A high yield is a sign that investors are worried about a business, but sometimes that concern is overwrought.

Amex trades at 17.3x forward earnings while Mastercard commands 32.5x, a valuation gap that raises a real question about which payments giant deserves the premium.

Both biotech ETFs hold about 30 healthcare names, but their index methods and fees differ enough to shape results for investors weighing sector exposure.

VCLT pays a 5.9% yield against 4.9% for VGLT, but its credit exposure shapes a different risk profile than government debt.

One is growing revenue above 100% by wiring AI data centers together, while the other collects royalties on nearly every mobile chip. Which one has the stronger case for your portfolio?

Revenue rose quarter over quarter, while non-GAAP operating margin expanded modestly, suggesting operating leverage.

Both funds currently yield the same 3.4%, yet their costs, geographic reach, and recent performance tell very different stories. Here is how the two stack up.

AI-driven cost savings and service pricing strategy are quietly reshaping the dealership's profit engine.

Margin expansion in a softer auto market signals the company's ability to offset production headwinds through operational discipline and new revenue streams.

Are Apple’s best days in the rearview mirror?

Casino exits cut revenue as prediction markets take center stage.

Multiyear automotive and data center contracts may serve as a hedge against smartphone-driven volatility.

Oil changes are driving repair ticket sizes to 2-3x their standalone value, a margin lever that may offset near-term sales pressure.

Fewer holdings, a higher fee, and a shallower drawdown set these two biotech funds apart in ways that could matter for long-term investors.

The beverage giant's asset-light model produces high-margin profits on mountains of revenue.

Factory cost cuts and pricing power are structurally protecting margins against raw material inflation.